Healthful aging mediated by inhibition of oxidative stress

SF Vatner, J Zhang, M Oydanich, T Berkman… - Ageing research …, 2020 - Elsevier
The progressive increase in lifespan over the past century carries with it some adversity
related to the accompanying burden of debilitating diseases prevalent in the older …

Role of AMPK/mTOR, mitochondria, and ROS in the pathogenesis of endometriosis

L Assaf, AA Eid, J Nassif - Life sciences, 2022 - Elsevier
Endometriosis is the presence of endometrial tissue outside the uterine cavity usually in the
ovaries, fallopian tube, and pelvic cavity. It's a chronic enigmatic gynecological condition …

[HTML][HTML] The circadian protein BMAL1 regulates translation in response to S6K1-mediated phosphorylation

JO Lipton, ED Yuan, LM Boyle, D Ebrahimi-Fakhari… - Cell, 2015 - cell.com
The circadian timing system synchronizes cellular function by coordinating rhythmic
transcription via a transcription-translational feedback loop. How the circadian system …

Beyond controlling cell size: functional analyses of S6K in tumorigenesis

X Wu, W **e, W **e, W Wei, J Guo - Cell Death & Disease, 2022 - nature.com
As a substrate and major effector of the mammalian target of rapamycin complex 1
(mTORC1), the biological functions of ribosomal protein S6 kinase (S6K) have been …

Distinct roles of mTOR targets S6K1 and S6K2 in breast cancer

S Sridharan, A Basu - International journal of molecular sciences, 2020 - mdpi.com
The mechanistic target of rapamycin (mTOR) is a master regulator of protein translation,
metabolism, cell growth and proliferation. It forms two complexes, mTOR complex 1 …

mTOR signaling for biological control and cancer

A Alayev, MK Holz - Journal of cellular physiology, 2013 - Wiley Online Library
Mammalian target of rapamycin (mTOR) is a major intersection that connects signals from
the extracellular milieu to corresponding changes in intracellular processes. When …

Tamoxifen action in ER-negative breast cancer

S Manna, MK Holz - Signal transduction insights, 2016 - journals.sagepub.com
Breast cancer is a highly heterogeneous disease. Tamoxifen is a selective estrogen receptor
(ER) modulator and is mainly indicated for the treatment of breast cancer in postmenopausal …

Estrogen-induced miR-196a elevation promotes tumor growth and metastasis via targeting SPRED1 in breast cancer

CF Jiang, ZM Shi, DM Li, YC Qian, Y Ren, XM Bai… - Molecular cancer, 2018 - Springer
Background Estrogen plays a critical role in breast cancer (BC) progression through
estrogen receptor (ER)-mediated gene regulation. Emerging studies suggest that the …

Mechanisms of resistance to CDK4/6 inhibitors and predictive biomarkers of response in HR+/HER2-metastatic breast cancer—a review of the literature

IM Stanciu, AI Parosanu, C Orlov-Slavu, IC Iaciu… - Diagnostics, 2023 - mdpi.com
The latest and newest discoveries for advanced and metastatic hormone receptor-positive
(HR+) and human epidermal growth factor receptor 2-negative (HER2-) breast cancer are …

The combination of rapamycin and resveratrol blocks autophagy and induces apoptosis in breast cancer cells

A Alayev, SM Berger, MY Kramer… - Journal of cellular …, 2015 - Wiley Online Library
Hyperactivation of the mechanistic target of rapamycin complex 1 (mTORC1) is a frequent
event in breast cancer and current efforts are aimed at targeting the mTORC1 signaling …